Skip to main content

Pounce™ Thrombectomy System Retrospective Registry

Recruiting · NCT05868161

Conditions: Peripheral Arterial Disease, Acute Limb Ischemia

At a glance

Research payments reported, 2025
$201,997
U.S. investigators named
10
Sites paid
9
Planned or actual enrollment
500

About the trial

Sponsor
SurModics, Inc.
Tested
Pounce Thrombectomy System (device)
Dates
Started 2023-04-18; completion 2026-07-31
Results posted
Not yet

The PROWL registry is an open-label retrospective, multi-center, US study of the Surmodics™ Pounce™ Thrombectomy System for the non-surgical removal of emboli and thrombi in the peripheral arterial vasculature.

From ClinicalTrials.gov, last updated 2025-09-11. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Surmodics, Inc. reported $201,997 in research payments for this study in 2025 (49 payments).

Products named: Prowl Registry

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.